|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ISRCTN |
|
Last refreshed on:
|
13 January 2015 |
|
Main ID: |
ISRCTN40686096 |
|
Date of registration:
|
30/09/2005 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
A pilot study of thalidomide therapy for alcoholic hepatitis
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
01/01/2006 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Completed |
|
URL:
|
http://isrctn.com/ISRCTN40686096 |
|
Study type:
|
Interventional |
|
Study design:
|
Randomised controlled trial (Treatment)
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
|
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
DH
Adams |
|
Address:
|
Liver Medicine
Queen Elizabeth Hospital
B15 2TH
Birmingham
United Kingdom |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Not provided at time of registration
Exclusion criteria: Not provided at time of registration
Age minimum:
Age maximum:
Gender:
Not Specified
|
|
Health Condition(s) or Problem(s) studied
|
Alcoholic hepatitis
Digestive System
Alcoholic liver disease
|
|
Intervention(s)
|
Patients referred to the Liver Unit for management of acute alcoholic hepatitis will be invited to participate in the trial provided that they fulfill inclusion criteria according to our proposed protocol. They will be given the study medications or placebo for a total of four weeks and will be monitored during and following this period of trial therapy.
Please note, this trial never started due to logistic problems.
|
|
Primary Outcome(s)
|
|
Survival or death, since severe AH carries a mortality of 50% within two months.
|
|
Secondary Outcome(s)
|
1. Onset of complications such as bacterial or fungal sepsis
2. Renal failure
3. Gastrointestinal haemorrhage
|
|
Secondary ID(s)
|
|
N0265006466
|
|
Source(s) of Monetary Support
|
|
University Hospital Birmingham NHS Trust (UK) - Internal funding
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|